MedRx Co., Ltd Announces Consolidated Financial Results for the Six Months Ended June 30, 2016; Provides Financial Guidance for the Year Ending Dec. 2016
MedRx Co. Ltd. announced consolidated financial results for the six months ended June 30, 2016. For the six months, the company reported operating loss of ¥742 million and loss attributable to owners of parent of ¥707 million or ¥92.1 per share on net sales of ¥10 million against operating loss of ¥446 million and loss attributable to owners of parent of ¥336 million or ¥50.32 per share on net sales of ¥15 million for the same period of last year.
For the year ending Dec. 2016, the company expects, operating loss of ¥1,608 million and loss attributable to owners of parent of ¥1,572 million or ¥196.9 per share on net sales of ¥29 million.